Syneos Health, Inc. - (SYNH): Price and Financial Metrics


Syneos Health, Inc. - (SYNH)

Today's Latest Price: $71.00 USD

4.30 (6.45%)

Updated Feb 20 3:49pm

Add SYNH to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

SYNH Stock Summary

  • SYNH's went public 5.29 years ago, making it older than merely 18.29% of listed US stocks we're tracking.
  • SYNH's current price/earnings ratio is 75.54, which is higher than 90.15% of US stocks with positive earnings.
  • Over the past twelve months, SYNH has reported earnings growth of 160.73%, putting it ahead of 92.77% of US stocks in our set.
  • Stocks that are quantitatively similar to SYNH, based on their financial statements, market capitalization, and price volatility, are PRAH, CCOI, ERI, SEAS, and CLH.
  • Visit SYNH's SEC page to see the company's official filings. To visit the company's web site, go to www.syneoshealth.com.
SYNH Daily Price Range
SYNH 52-Week Price Range

SYNH Stock Price Chart More Charts


SYNH Price/Volume Stats

Current price $71.00 52-week high $72.44
Prev. close $66.70 52-week low $36.72
Day low $67.55 Volume 840,045
Day high $72.44 Avg. volume 403,341
50-day MA $61.14 Dividend yield N/A
200-day MA $52.89 Market Cap 7.37B

Syneos Health, Inc. - (SYNH) Company Bio


Syneos Health, formerly INC Research Holdings, provide the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The company was founded in 2010 and is based in Raleigh, North Carolina.

SYNH Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$71.00$33.67-49%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Syneos Health Inc. To summarize, we found that Syneos Health Inc ranked in the 38st percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for Syneos Health Inc ended up being:

  • The stock's equity weight, or the proportion of capital from equity relative to debt, is 70. Notably, its equity weight is greater than merely 20.56% of US equities in the Healthcare sector yielding a positive free cash flow.
  • Syneos Health Inc's weighted average cost of capital (WACC) is 8%; for context, that number is higher than only 24.21% of tickers in our DCF set.
  • Syneos Health Inc's effective tax rate, as measured by taxes paid relative to net income, is at 17 -- greater than 68.62% of US stocks with positive free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-50%
1%-49%
2%-49%
3%-48%
4%-48%
5%-47%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as SYNH, try HRC, IONS, NVS, GSK, and MCK.


SYNH Latest News Stream


Event/TimeNews Detail
Loading, please wait...

SYNH Latest Social Stream


Loading social stream, please wait...

View Full SYNH Social Stream

SYNH Price Returns

1-mo 11.23%
3-mo 34.29%
6-mo 42.46%
1-year 29.42%
3-year 30.28%
5-year 177.24%
YTD 19.38%
2019 51.14%
2018 -9.75%
2017 -17.11%
2016 8.43%
2015 88.83%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9512 seconds.